Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

The prophylaxis of medical patients for thromboembolism pilot study.

Lederle FA, Sacks JM, Fiore L, Landefeld CS, Steinberg N, Peters RW, Eid AA, Sebastian J, Stasek JE Jr, Fye CL.

Am J Med. 2006 Jan;119(1):54-9.

PMID:
16431185
3.

A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N.

N Engl J Med. 1999 Sep 9;341(11):793-800.

4.

Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).

Sorino M, Colonna P, De Luca L, Carerj S, Oliva E, De Tommasi SM, Conti U, Iacopi F, D'Agostino C, D'Amato N, Pettinati G, Montericcio V, Cualbu A, De Luca I.

J Cardiovasc Med (Hagerstown). 2007 Dec;8(12):1034-42.

PMID:
18163016
5.

Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study.

Marlovits S, Striessnig G, Schuster R, Stocker R, Luxl M, Trattnig S, Vécsei V.

Arthroscopy. 2007 Jul;23(7):696-702.

PMID:
17637403
6.

Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.

Hull RD, Schellong SM, Tapson VF, Monreal M, Samama MM, Turpie AG, Wildgoose P, Yusen RD.

J Thromb Thrombolysis. 2006 Aug;22(1):31-8.

PMID:
16786230
7.

Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.

Peterman CM, Kolansky DM, Spinler SA.

Pharmacotherapy. 2006 Aug;26(8):1086-90.

PMID:
16863485
8.

Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.

Tetri S, Hakala J, Juvela S, Saloheimo P, Pyhtinen J, Rusanen H, Savolainen ER, Hillbom M.

Thromb Res. 2008;123(2):206-12. doi: 10.1016/j.thromres.2008.01.018. Epub 2008 Apr 16.

PMID:
18420258
9.

Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.

Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA.

Ann Intern Med. 2007 Feb 20;146(4):278-88.

PMID:
17310052
10.

Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).

Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J; ECHOS Trial Group.

Int Angiol. 2006 Dec;25(4):335-42.

PMID:
17164738
11.

Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?

Priglinger U, Delle Karth G, Geppert A, Joukhadar C, Graf S, Berger R, Hülsmann M, Spitzauer S, Pabinger I, Heinz G.

Crit Care Med. 2003 May;31(5):1405-9.

PMID:
12771610
12.

Dalteparin: new indication. Prophylaxis in medical patients: no advance.

[No authors listed]

Prescrire Int. 2005 Feb;14(75):14-5.

PMID:
15751168
13.

Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.

Kahn SR, Panju A, Geerts W, Pineo GF, Desjardins L, Turpie AG, Glezer S, Thabane L, Sebaldt RJ; CURVE study investigators.

Thromb Res. 2007;119(2):145-55. Epub 2006 Mar 3.

PMID:
16516275
14.

Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.

Verso M, Agnelli G, Bertoglio S, Di Somma FC, Paoletti F, Ageno W, Bazzan M, Parise P, Quintavalla R, Naglieri E, Santoro A, Imberti D, Sorarù M, Mosca S.

J Clin Oncol. 2005 Jun 20;23(18):4057-62. Epub 2005 Mar 14.

15.

The post-discharge prophylactic management of the orthopedic patient with low-molecular-weight heparin: enoxaparin.

Nilsson PE, Bergqvist D, Benoni G, Björgell O, Fredin H, Hedlund U, Nicolas S, Nylander G.

Orthopedics. 1997 Feb;20 Suppl:22-5.

PMID:
9048404
16.

Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis.

Chong BH, Brighton TA, Baker RI, Thurlow P, Lee CH; ASTH DVT Study Group.

J Thromb Thrombolysis. 2005 Jun;19(3):173-81.

PMID:
16082604
17.

Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany.

Schädlich PK, Schmidt-Lucke C, Huppertz E, Lehmacher W, Nixdorff U, Stellbrink C, Brecht JG.

Am J Cardiovasc Drugs. 2007;7(3):199-217.

PMID:
17610347
18.

Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.

Bui HT, Krisnaswami A, Le CU, Chan J, Shenoy BN.

Am J Cardiol. 2009 Nov 15;104(10):1429-33. doi: 10.1016/j.amjcard.2009.06.065. Epub 2009 Sep 26.

PMID:
19892063
19.

[Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].

Omran H, Hammerstingl C, Paar WD; Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events.

Med Klin (Munich). 2007 Oct 15;102(10):809-15. German.

PMID:
17928964
20.

Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial.

Kalfarentzos F, Stavropoulou F, Yarmenitis S, Kehagias I, Karamesini M, Dimitrakopoulos A, Maniati A.

Obes Surg. 2001 Dec;11(6):670-6.

PMID:
11775562
Items per page

Supplemental Content

Write to the Help Desk